Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Vet J ; 176(2): 197-204, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-17400007

RESUMEN

The aim of this study was to investigate drug resistance and the genetic relatedness of erythromycin-resistant Streptococcus spp. from different animals and humans in Taiwan. Cumulatively, 248 isolates were collected from 15 animal species and human patients and the susceptibilities of the isolates to six antimicrobial agents including azithromycin (AZI), clarithromycin (CLAR), erythromycin (ERY), spiramycin (SPIR), amoxicillin (AMO), and enrofloxacin (ENRO) were determined by the agar dilution method. The results indicated that resistance among the 248 strains was highest for SPIR, followed by ENRO, CLAR, ERY, AZI, and AMO. The most common resistotypes of the isolates from mammals and aquatic animals were AZI-CLAR-ERY-SPIR (27.5%) and SPIR (55.1%), respectively. The presence of ERY-resistant genes was confirmed by PCR. The erm gene was amplified from 28 isolates (20.6%) by PCR for further investigation. The predominant erm gene in the ERY-resistant isolates was the erm(B) gene. The phylogenetic analysis of the erm(B) gene results indicated that there was a close genetic relationship among all the strains but the genotypic clusters did not show clear segregation of the isolates according to the source or region.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Eritromicina/farmacología , Metiltransferasas/genética , Infecciones Estreptocócicas/microbiología , Streptococcus/efectos de los fármacos , Streptococcus/genética , Animales , Proteínas Bacterianas/metabolismo , ADN Bacteriano/química , ADN Bacteriano/genética , Farmacorresistencia Bacteriana , Farmacorresistencia Bacteriana Múltiple , Humanos , Metiltransferasas/metabolismo , Pruebas de Sensibilidad Microbiana , Filogenia , Reacción en Cadena de la Polimerasa , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus/enzimología
2.
J Aquat Anim Health ; 19(3): 168-78, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18201058

RESUMEN

The aims of this study were to purify and localize the nitric oxide synthases (NOSs) from hybrid tilapia (Nile tilapia Oreochromis niloticus x Mozambique tilapia O. mossambicus). The purification procedures involved affinity chromatography with a 2', 5'-ADP-agarose 4B column and ion exchange with a diethylaminoethanol Bio-Gel A column. The results from gel filtration assays showed that the molecular weights of neuronal NOS (nNOS) and inducible NOS (iNOS) were 178 and 120 kDa, respectively. The sodium dodecyl sulfate-polyacrylamide gel electrophoresis results showed that there were three bands with molecular weights of 89, 47, and 29 kDa from the purified nNOS. However, only one band, with a molecular weight of 120 kDa, appeared on the gel from the purified iNOS. Hybrid tilapia nNOS was a dimer structure, while iNOS appeared to be a monomer structure. Moreover, our results revealed that the activities of nNOS and iNOS were significantly higher after the addition of Ca+2 or Mg+2 ions individually. However, when L-arginine and NADPH were present, the addition of 1 mM of either ion did not further increase the activity. The chemical L-N(G)-methyl-L-arginine could inhibit the activities of the purified NOSs with or without L-arginine. Western blot analyses showed only an 89-kDa immunoreactive band from the extracts of cerebrum; however, we did not find the specific bands in other tissues, such as gill, intestine, liver, spleen, and anterior kidney. We found another 120-kDa immunoreactive protein band with the rabbit antirat iNOS serum against iNOS from the extracts of anterior kidney and spleen. The results of immunohistochemistry with the rabbit antihuman nNOS serum indicated that the nNOS existed in the cerebellum, olfactory bulb, diencephalons, and nerve cell bodies and neuronal fibers of the spinal cord. Interestingly, only macrophages from anterior kidney and spleen showed positive reactions with the rabbit antirat iNOS serum. In the same way, the endothelial NOS (eNOS) located in the heart and epithelial cells of the blood vessels reacted positively with the rabbit antibovine eNOS serum.


Asunto(s)
Cerebelo/enzimología , Cíclidos/metabolismo , Cruzamientos Genéticos , Óxido Nítrico Sintasa/aislamiento & purificación , Tilapia/metabolismo , Animales , Cromatografía de Afinidad/veterinaria , Cromatografía en Gel/veterinaria , Electroforesis en Gel de Poliacrilamida/veterinaria , Femenino , Masculino , Peso Molecular , Óxido Nítrico Sintasa de Tipo I/aislamiento & purificación , Óxido Nítrico Sintasa de Tipo II/aislamiento & purificación , Especificidad de la Especie
3.
J Aquat Anim Health ; 19(1): 49-59, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18236632

RESUMEN

The aim of this study was to evaluate the immune responses in hybrid tilapia (Nile tilapia Oreochromis niloticus x Mozambique tilapia O. mossambicus) and Japanese eels Anguilla japonica after treatment with five glycans: barley, krestin, MacroGard, scleroglucan, and zymosan. The effects of the glycans on the innate immune responses of the fish were investigated using the phagocytic index (PI), lysozyme activity, complement opsonization, and activation assay. The results of the lysozyme assay demonstrated that the lysozyme activities increased after treatment with glycans. Moreover, based on the PI, treatment with each of the five glycans resulted in increased phagocytic activities in anterior kidney and peripheral blood phagocytes in both tilapia and Japanese eels. The opsonic effect of complement on phagocytosis in tilapia and Japanese eels were investigated using baker's yeast, which served as the activator in the classical complement pathway (CCP) and in the alternative complement pathway (ACP). Tilapia and Japanese eel sera that were treated with glycans greatly enhanced phagocytosis. The classical pathway--hemolytic complement titer (CH50) of Japanese eels treated with glycans was slightly increased in vitro and in vivo. While glycan treatment enhanced the CCP of both species in vitro and in vivo, the alternative pathway-hemolytic complement titer (ACH50) was only increased in vitro and in vivo in glycan-treated tilapia. Thus, it follows that the ACP must have been activated in tilapia treated with glycans. However, in Japanese eels, the ACH50 of the ACP activation assay was undetected in vitro or in vivo due to possible unknown factors in the Japanese eel serum that caused lysis of the rabbit red blood cells. Our study investigated the effects of glycans used to enhance phagocytosis and activate both of the complement pathways involved in stimulating the innate immune responses of Japanese eels and tilapia.


Asunto(s)
Activación de Complemento/efectos de los fármacos , Vía Alternativa del Complemento/efectos de los fármacos , Anguilas/inmunología , Fagocitosis/efectos de los fármacos , Polisacáridos/farmacología , Tilapia/inmunología , Animales , Relación Dosis-Respuesta Inmunológica , Glucanos/farmacología , Hordeum , Inmunidad Innata , Muramidasa/metabolismo , Proteoglicanos/farmacología , Zimosan/farmacología , beta-Glucanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA